Altss Research / Venture case 13
Babylon Health
Babylon's U.K. holding company entered administration in August 2023. The U.K. healthcare business and selected assets were acquired by eMed, which said that patient services would continue.
Altss Research · Evidence reviewed · Historical event record
Historical private valuation
$1.5bn pre-moneyVostok New Ventures' 2019 annual report identifies a completed $400m first closing on August 2, 2019 at $1.5bn pre-money. This avoids treating a proposed final-round amount or later SPAC value as the benchmark.
Bankruptcy / insolvency
No sale priceU.K. holding company entered administration. Official appointment date for administrators to Babylon Group Holdings Limited, rather than a claim that all Babylon services ended.
These figures have different valuation bases and dates. Their difference is not a measure of investor losses. Methodology ↗
The documented timeline
Private round first closing
An investor's annual report confirms the completed first close and $1.5bn pre-money valuation.
Administrators appointed
The Gazette records the appointment for the U.K. holding company.
Buyer confirmed U.K. continuation
eMed announced the acquisition of Babylon Healthcare Services Limited and specific assets of two related companies, with continuity of clinical services.
Source documents
Publication and access dates identify the evidence used for this case.
Vostok New Ventures · Primary source · Publication date not stated · Accessed Oct 26, 2026
The Gazette · Primary source · Published Sep 6, 2023 · Accessed Oct 26, 2026
eMed Healthcare UK via PR Newswire · Primary source · Published Oct 19, 2023 · Accessed Oct 26, 2026
Logo: Babylon Health logo source. Company trademark rights remain.
